FDA Panel Backs Pfizer’s COVID Booster for 65 and Older, Those at High Risk
A US Food and Drug Administration (FDA) advisory panel voted unanimously today to recommend a booster dose of Pfizer’s mRNA COVID-19 vaccine for those 65 and older, and for those at high risk of severe outcomes from the disease, including healthcare workers. This followed an earlier 16-2 vote by the […]